. 2019 Mar 14;32(1):58–64. doi: 10.4103/tcmj.tcmj_220_18

Table 2.

Craving - mean ratings at baseline and 4 days

Day/group	Placebo (n=21)	16 mg (n=20)		32 mg (n=20)	F		df	P^a
Baseline^b	9.71±0.64	9.85±0.48		9.10±2.40	1.517		2	0.228
Day 1^b	9.28±1.007	5.95±1.79		5.50±3.88	13.909		2	<0.0005
Day 2^b	7.90±1.17	1.20±1.10		3.70±3.54	47.352		2	<0.0005
Day 3^b	7.23±1.22	0.00±0.00		2.50±3.03	78.765		2	<0.0005
Day 4^b	5.95±1.46	0.00±0.00		1.70±2.57	78.765		2	<0.0005
F	82.730	463.960		46.284	66.418
P	<0.0005	<0.0005		<0.0005
df	4	4		4
^aThe three groups were compared by ANOVA, ^bNumbers shown are means±SD. SD: Standard deviation

Mean craving^b			Mean±SD			P^a

Placebo versus 16 mg			4.61±0.505			<0.0005
Placebo versus 32 mg			3.51±0.505			<0.0005
16 mg versus 32 mg			1.100±0.511			0.089

^aThe three groups were compared by post hoc t-tests, ^bNumbers shown are means±SD. SD: Standard deviation